
Publication
Advance Notice By-Law 2.0
Advance notice by-laws are a long-standing, commonly accepted corporate governance tool in Canada.
Author:
Canada | Publication | December 23, 2020
Despite the recent announcement of Ontario’s province-wide lockdown now expected to come into effect on Boxing Day, employers may still find some cheer in learning that the COVID-19 period has recently been extended to July 3, 2021. Until then, related measures under the Employment Standards Act, 2000 (ESA), such as those pertaining to the infectious disease emergency leave (IDEL) and temporary layoffs, remain in effect.
On December 17, Ontario filed Regulation 765/20 under the ESA, which extends the COVID 19 period in Regulation 228/20 until July 3, 2021. As a result, the temporary measures set out in Regulation 228/20 will continue to apply. Specifically, for non-unionized employees with a temporary reduction in their hours of work or wages for reasons related to the designated infectious disease during the COVID-19 period:
On July 4, 2021, the regular rules regarding layoffs will resume, and the “temporary layoff clock,” so to speak, starts ticking again.
The rollout of the COVID-19 vaccine is now underway. It will proceed in phases, prioritizing vulnerable or higher-risk populations, before access by the general public by the end of 2021. However, it is not yet clear how the vaccine will affect entitlement to IDEL.
Notably, IDEL’s purpose was to provide employees with protections in employment where COVID-19 factors, outside their control, prevented their employment. Therefore, for employees not vaccinated because it is not yet available to them, as well as employees with children who have not received the vaccine, it may be that IDEL would continue to apply.
However, it is unclear whether IDEL would apply to employees for whom the vaccination is available, but who choose not to receive it either for themselves or their children. Here, the choice to vaccinate could be the result of factors outside or within the employee’s control. The extent to which that matters for IDEL eligibility may very well morph into a hot topic next year.
To date, no legal guidance from Ontario has been published on this issue. Nevertheless, a recent news release regarding the plan developed by Ontario’s COVID-19 Vaccine Distribution Task Force advised that in phases 1 and phase 2 of the rollout, the COVID-19 vaccine “will be administered” to certain vulnerable or higher-risk populations. In phase 3, however, the vaccine will be available to any Ontarian “who wishes” to be immunized, but it “will not be mandated.” How this will – or won’t – affect entitlement to IDEL remains to be seen. We will monitor developments closely.
Publication
Advance notice by-laws are a long-standing, commonly accepted corporate governance tool in Canada.
Publication
An Ontario court has delivered yet another unfortunate termination clause decision.
Publication
With the suspension of the USPTO’s Climate Change Mitigation Pilot, the Canadian Advanced Examination for Green Technologies mechanism can be used to accelerate examination for a corresponding Canadian application, which can then generate a work product usable for expediting examination in various patent offices around the world using the Patent Prosecution Highway (PPH), reducing the time from patent application filing to grant.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025